Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Revenue

Xbrane Biopharma AB had revenue of 54.78M SEK in the quarter ending September 30, 2026, with 441.31% growth. This brings the company's total for the last twelve months to 127.95M, down -38.80% year-over-year. In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M with 2.87% growth. That makes Xbrane Biopharma AB the 36,115th largest company in the world by revenue and 478th in Sweden.

• Revenue (ttm): 127.95M
• Revenue Growth: -38.80%
• P/S Ratio: 2.28
• Revenue / Employee: 4.41M
• Employees: 29
• Market Cap: 260.66M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 84.30M 55.3%
• Germany 67.50M 44.3%
• Others 600.00K 0.4%

Fiscal year ended Dec 31, 2025 See the full Xbrane Biopharma AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	152.35M	4.26M	2.87%
Dec 31, 2024	148.10M	-90.63M	-37.96%
Dec 31, 2023	238.73M	181.11M	314.33%
Dec 31, 2022	57.62M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	20.49M	-286.00K	-1.38%
Dec 31, 2017	20.77M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	392.86K	203.23K	107.17%
Dec 31, 2014	189.63K	104.00	0.05%
Dec 31, 2013	189.52K	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error